InvestorsHub Logo
icon url

Lykiri

02/18/19 3:55 PM

#214996 RE: AVII77 #214994

AVII77,

Thanks!

It was more in the sense of cross-over.

Almost 90% of patients have received DCVax-L at some point. -67% received it at randomization, and the rest received DCVax-L after documented disease progression.



Wait and see???